BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 7537927)

  • 1. Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas.
    Kakehi Y; Ozdemir E; Habuchi T; Yamabe H; Hashimura T; Katsura Y; Yoshida O
    Jpn J Cancer Res; 1998 Feb; 89(2):214-20. PubMed ID: 9548450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
    Offner FA; Schäfer G; Hittmair A; Ofner D; Grünewald K; Weyrer K; Mattern D; Eberle J; Mikuz G; Feichtinger H
    Verh Dtsch Ges Pathol; 1993; 77():241-6. PubMed ID: 7511289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example.
    Sekula P; Pressler JB; Sauerbrei W; Goebell PJ; Schmitz-Dräger BJ
    BMJ Open; 2016 Aug; 6(8):e009972. PubMed ID: 27531721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of mdm-2 and p53 protein in transitional cell carcinoma.
    Barbareschi M; Girlando S; Fellin G; Graffer U; Luciani L; Dalla Palma P
    Urol Res; 1995; 22(6):349-52. PubMed ID: 7537927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation.
    Pruneri G; Pignataro L; Carboni N; Luminari S; Capaccio P; Neri A; Buffa R
    Mod Pathol; 1997 Aug; 10(8):785-92. PubMed ID: 9267820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder.
    Uchida T; Minei S; Gao JP; Wang C; Satoh T; Baba S
    Oncol Rep; 2002; 9(2):253-9. PubMed ID: 11836589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma.
    Moch H; Sauter G; Gasser TC; Buchholz N; Bubendorf L; Richter J; Jiang F; Dellas A; Mihatsch MJ
    Urol Res; 1997; 25 Suppl 1():S25-30. PubMed ID: 9079753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer.
    Moch H; Sauter G; Moore D; Mihatsch MJ; Gudat F; Waldman F
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):329-34. PubMed ID: 7509541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma.
    Gorgoulis VG; Rassidakis GZ; Karameris AM; Papastamatiou H; Trigidou R; Veslemes M; Rassidakis AN; Kittas C
    Mod Pathol; 1996 May; 9(5):544-54. PubMed ID: 8733770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
    Reifenberger G; Liu L; Ichimura K; Schmidt EE; Collins VP
    Cancer Res; 1993 Jun; 53(12):2736-9. PubMed ID: 8504413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue.
    Dei Tos AP; Doglioni C; Laurino L; Barbareschi M; Fletcher CD
    Histopathology; 1993 Jan; 22(1):45-50. PubMed ID: 8436341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
    Finlay CA
    Mol Cell Biol; 1993 Jan; 13(1):301-6. PubMed ID: 8417333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 gene amplification in metastatic osteosarcoma.
    Ladanyi M; Cha C; Lewis R; Jhanwar SC; Huvos AG; Healey JH
    Cancer Res; 1993 Jan; 53(1):16-8. PubMed ID: 8416741
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.